Dr Lal Pathlabs Share Price Target 2026, 2027, 2030, 2040, 2050
Dr Lal PathLabs is a well-known Indian company that provides many kinds of medical tests and health services. It offers simple and advanced tests in areas like pathology, radiology, genetics, and microbiology, including tests for dengue, diabetes, infections, and autoimmune diseases. The company has a big network of labs, patient service centres, and it serves people, hospitals, doctors, and companies. It also works in other countries like Nepal, Saudi Arabia, Nigeria, Bangladesh, and Sri Lanka.
What is Dr Lal Pathlabs Ltd NSE: LALPATHLAB?
Dr Lal PathLabs, established in 1949 in Delhi by Dr S. K. Lal. It is one of India’s biggest and most trusted medical testing companies. It began as a small lab and has now grown into a large network with many labs and thousands of testing centres all over India. The company does simple and advanced health tests, like blood tests, urine tests, thyroid tests, diabetes tests, infection tests, and full-body checkups. It also offers special tests for the heart and other organs. Because it has centres in many cities and towns, people can easily get tested, and its good quality makes doctors, hospitals, and patients trust its reports.
It started as a small lab in Delhi many years ago. Over time, it grew into one of the biggest testing networks in India. Today, it has many labs and thousands of centres where people can give their samples. This large network helps people in villages, towns, and cities get important health tests easily. The company keeps growing by adding new machines, hiring trained staff, and opening new centres in places where testing is needed. In 2026, its share price target would be ₹2482, as per stock market analysts.
According to stock market analysts, its share price would be between ₹1235 to ₹2482 in 2026.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2026 | 1235 | 2482 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 1288 | 1558 |
| फ़रवरी | 1254 | 1670 |
| मार्च | 1235 | 1756 |
| अप्रैल | 1367 | 1867 |
| मई | 1445 | 1934 |
| जून | 1587 | 1976 |
| जुलाई | 1665 | 2065 |
| अगस्त | 1710 | 2150 |
| सितंबर | 1665 | 2200 |
| अक्टूबर | 1778 | 2345 |
| नवंबर | 1874 | 2441 |
| दिसम्बर | 1957 | 2482 |
It offers a very long list of tests for different health needs. These include basic tests like blood sugar, thyroid, kidney, liver, cholesterol, urine tests, and tests for infections. It also offers special tests like genetic tests, allergy tests, hormone tests, cancer-related tests, vitamin tests, and tests for autoimmune diseases. This helps doctors quickly find health problems and give the right treatment. The company keeps adding new tests as medical needs change. In 2027, its share price target would be ₹6308, as per stock market analysts.
Its share price would be between ₹4725 to ₹6308 in 2027, as per stock market analysts.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2027 | 4725 | 6308 |
It also provides services like X-rays, ultrasounds, CT scans, and other scans. These tests help doctors see inside the body and find problems that blood tests cannot show. Imaging is very important for spotting bone fractures, organ issues, infections, tumours, and other health problems. The company uses modern machines and trained radiologists to make sure the images are clear and the reports are correct. In 2028, its share price target would be ₹7572, as per stock market analysts.
Its share price would be between ₹6180 to ₹7572 in 2028, as per stock market analysts.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2028 | 6180 | 7572 |
It has many health checkup packages for different people. These include full-body checkups, heart checkups, diabetes checkups, pregnancy packages, and checkups for older people. Each package includes important tests that help people know their overall health and find any early problems. These packages cost less than doing all tests separately, so they are more affordable. Many people choose them for regular health checkups because early testing helps avoid serious health issues and keeps them healthy for a long time. In 2029, its share price target would be ₹8728, as per stock market analysts.
Its share price would be between ₹7378 to ₹8728 in 2029, as per stock market analysts.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2029 | 7378 | 8728 |
It also provides testing services to hospitals, clinics, and corporate companies. Hospitals use the company’s labs to get fast and correct results for patients. Corporate companies use these services for employee health checkups, pre-employment tests, food handling tests, and other work-related tests. These services help keep employees healthy and workplaces safe. By working with many organisations, the company helps a large number of people stay healthy. This makes the company important for both individuals and businesses. In 2030, its share price target would be ₹9842, as per stock market analysts.
Its share price would be between ₹8610 to ₹9842 in 2030, as per stock market analysts.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2030 | 8610 | 9842 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 8610 | 8841 |
| फ़रवरी | 8707 | 8934 |
| मार्च | 8734 | 9058 |
| अप्रैल | 8774 | 9102 |
| मई | 8885 | 9187 |
| जून | 8910 | 9257 |
| जुलाई | 8941 | 9341 |
| अगस्त | 8990 | 9398 |
| सितंबर | 9054 | 9445 |
| अक्टूबर | 9112 | 9541 |
| नवंबर | 9242 | 9667 |
| दिसम्बर | 9414 | 9842 |
It uses advanced machines and modern technology to give fast and correct reports. Its automated systems help handle samples safely and reduce mistakes. Digital tools help store patient information, track samples, and give online reports. People can also book tests online and make digital payments easily. The company keeps updating its machines and software to follow the latest medical rules. This use of technology helps the company give reliable results and makes testing simple, quick, and safe for patients. In 2040, its share price target would be ₹15410, as per stock market analysts.
Its share price would be between ₹14061 to ₹15410 in 2040, as per stock market analysts.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2040 | 14061 | 15410 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 14061 | 14474 |
| फ़रवरी | 14101 | 14557 |
| मार्च | 14154 | 14641 |
| अप्रैल | 14278 | 14788 |
| मई | 14357 | 14890 |
| जून | 14415 | 14978 |
| जुलाई | 14587 | 15074 |
| अगस्त | 14741 | 15168 |
| सितंबर | 14858 | 15190 |
| अक्टूबर | 14900 | 15231 |
| नवंबर | 14934 | 15289 |
| दिसम्बर | 15074 | 15410 |
The company has a large team of trained professionals, like pathologists, lab technicians, radiologists, sample collectors, and customer support staff. All of them follow safety rules, keep the labs clean, and handle samples carefully. The staff receives regular training to learn new methods and use new technology. They make sure that reports are correct and patients are treated kindly. Their skills and hard work help the company maintain trust and provide good service. In 2050, its share price target would be ₹20680, as per stock market analysts.
Its share price would be between ₹19458 to ₹20680 in 2050, as per stock market analysts.
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2050 | 19458 | 20680 |
| महीना | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| जनवरी | 19458 | 19841 |
| फ़रवरी | 19500 | 19987 |
| मार्च | 19584 | 20104 |
| अप्रैल | 19625 | 20125 |
| मई | 19678 | 20174 |
| जून | 19785 | 20212 |
| जुलाई | 19852 | 20275 |
| अगस्त | 19930 | 20315 |
| सितंबर | 19984 | 20374 |
| अक्टूबर | 20102 | 20418 |
| नवंबर | 20158 | 20525 |
| दिसम्बर | 20257 | 20680 |
Should I buy Dr Lal Pathlabs stock?
| वर्ष | न्यूनतम मूल्य (Rs) | अधिकतम मूल्य (Rs) |
| 2026 | 1235 | 2387 |
| 2027 | 4725 | 6308 |
| 2028 | 6180 | 7572 |
| 2029 | 7378 | 8728 |
| 2030 | 8610 | 9842 |
| 2040 | 14061 | 15410 |
| 2050 | 19458 | 20680 |
This stock could be a good stock for long-term investment because the company is strong, trusted, and growing its labs across India. But in the short term, its profit might go down a little because it is spending money to expand, and there is competition. So it is a good choice if you want slow and steady growth and are okay with small ups and downs in the stock price.
Dr Lal Pathlabs earnings results
| मार्च 2020 | मार्च 2021 | मार्च 2022 | मार्च 2023 | मार्च 2024 | मार्च 2025 | टीटीएम | |
| बिक्री + | 1,330 | 1,581 | 2,087 | 2,017 | 2,227 | 2,461 | 2,600 |
| व्यय + | 987 | 1,145 | 1,526 | 1,527 | 1,617 | 1,764 | 1,860 |
| परिचालन लाभ | 344 | 436 | 561 | 490 | 609 | 698 | 739 |
| OPM % | 26% | 28% | 27% | 24% | 27% | 28% | 28% |
| अन्य आय + | 55 | 51 | 52 | 42 | 69 | 91 | 104 |
| ब्याज | 15 | 16 | 30 | 38 | 29 | 22 | 20 |
| व्याख्या | 73 | 77 | 108 | 150 | 144 | 142 | 147 |
| कर से पहले लाभ | 310 | 394 | 475 | 344 | 505 | 625 | 676 |
| कर | 27% | 25% | 26% | 30% | 28% | 21% | |
| नेट प्रॉफिट + | 228 | 296 | 350 | 241 | 362 | 492 | 540 |
| रुपये में ईपीएस | 27.11 | 34.99 | 41.37 | 28.65 | 42.85 | 58.28 | 63.84 |
| लाभांश भुगतान % | 44% | 57% | 29% | 42% | 56% | 0% | — |
कुंजी मीट्रिक
| TTM PE Ratio | PB अनुपात | लाभांश प्राप्ति | सेक्टर PE | सेक्टर PB | सेक्टर Div Yld |
| 47.67 | 11.54 | 0.79% | 37.31 | 5.90 | 0.58% |
Peers & तुलना
| स्टॉक | पीई अनुपात | PB अनुपात | लाभांश प्राप्ति |
| Dr. Lal PathLabs Ltd | 52.29 | 11.54 | 0.79% |
| Max Healthcare Institute Ltd | 105.10 | 12.05 | 0.13% |
| Apollo Hospitals Enterprise Ltd | 72.95 | 9.50 | 0.17% |
| Fortis Healthcare Ltd | 89.62 | 7.57 | 0.11% |
Is Dr Lal Pathlabs stock good to buy? (bull case & bear case)
बुल केस:
- The company has zero debt, so it is safe and stable.
- Profit has grown well, with some quarters showing 16% and even 80% growth compared to last year.
- The company’s revenue keeps increasing every year.
- The health test market in India is growing by 8%–10% every year, which helps the company grow.
- It is opening many new labs in different cities and towns.
- The company is a trusted brand, so more people choose it for tests.
- Its big network and good cash flow help it grow for the long term.
भालू का मामला:
- Profit margins are going down because the company is spending more on expansion, falling by 1%–2% in some quarters.
- There is strong competition from many small labs and new online testing companies offering cheaper tests.
- If the company’s growth slows even a little, the high stock price can fall quickly.
- More than 50% of revenue comes from North India, so slow growth there can hurt the company.
निष्कर्ष
It is a well-known and trusted testing company with many labs, growing profits, and no debt, which makes it a safe choice for long-term investors. The demand for health tests in India is also increasing, which helps the company grow in the future. But the stock price is already high, profits may go down a little because the company is spending money to open more labs, and there is strong competition, so the share price may go up and down in the short term. It is a good stock if you want slow, steady growth and do not mind small ups and downs.
